Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biochanin A promotes KLF6 stabilization to induce ferroptosis and suppress colorectal cancer progression. | Cell Signal | 2026 | 42754129 | PubTator, text mining | PubMed |
| Lidocaine suppresses glioma growth through DPP9-mediated ferroptosis. | Brain Res | 2026 | 42753884 | PubTator, text mining | PubMed |
| Calcium licenses lipid droplets for ferroptosis: A PKCβ-ACSL4-ALOX15 phosphorylation relay. | Cell Calcium | 2026 | 42753351 | PubTator, text mining | PubMed |
| Resident immune cell neighborhoods associate with protein kinase pRIPK3 and fatty acid ligase FACL4 expression during cell injury in ANCA associated vasculitis and lupus nephritis. | Kidney Int | 2026 | 42744245 | PubTator, text mining | PubMed |
| Comorbid mechanisms of neuroinflammation and astrocytic ferroptosis in neurological disorders: A vicious cycle (Review). | Biomed Rep | 2026 | 42741546 | PubTator, text mining | PubMed |
| A Randomized Controlled Trial: Efficacy of Wangbi Capsule Plus Conventional Therapy for Knee Osteoarthritis and Its Modulation of the Ferroptosis Pathway. | Curr Rheumatol Rev | 2026 | 42736683 | PubTator, text mining | PubMed |
| NMN mitigates LPS-induced liver injury by inhibiting ferroptosis via suppression of the cGAS-STING-ACSL4 axis. | Pharmacol Res | 2026 | 42735732 | PubTator, text mining | PubMed |
| SGK2 Promotes NEDD4L-Mediated ACSL4 Ubiquitination to Inhibit Ferroptosis and Alleviate Diabetic Kidney Disease. | Antioxid Redox Signal | 2026 | 42730475 | PubTator, text mining | PubMed |
| MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy. | Nat Cancer | 2026 | 42728394 | PubTator, text mining | PubMed |
| Ferroptosis in Low-Density Neutrophils of Tuberculosis Patients Suppresses Bactericidal Function. | Clin Exp Pharmacol Physiol | 2026 | 42725380 | PubTator, text mining | PubMed |
| Multifunctional Nanovaccine-Radiotherapy Synergy Drives Anti-Tumor Immunity via Multi-Cascade Cell Death for Pancreatic Cancer Therapy. | Adv Sci (Weinh) | 2026 | 42723174 | PubTator, text mining | PubMed |
| The research landscape of ferroptosis in ischemic stroke: a bibliometric analysis of the literature from 2017 to 2025 based on the WOS and PubMed databases. | Front Cell Neurosci | 2026 | 42719580 | PubTator, text mining | PubMed |
| MGAT5 regulates ferroptosis via the Nrf2/HO-1 signaling pathway in diabetic nephropathy. | Open Life Sci | 2026 | 42713568 | PubTator, text mining | PubMed |
| Ginsenoside Rb1 alleviates AS co-depression disease by targeting the LPCAT3 and modulating the ACSL4/LPCAT3/ALOX15 ferroptosis pathway. | Phytomedicine | 2026 | 42710215 | PubTator, text mining | PubMed |
Ferroptosis-driven stromal immune evasion and melatonin receptor suppression as novel predictive biomarkers of immunotherapy response in oral squamous cell carcinoma: a single-cell transcriptomic study. | Front Genet | 2026 | 42707754 | PubTator, text mining | PubMed |
| METTL3 Promotes the Growth of Triple-Negative Breast Cancer Cells by Modulating Ferroptosis-Related Oxidative Stress via the ELF1/GPX4 Axis. | Asia Pac J Clin Oncol | 2026 | 42706600 | PubTator, text mining | PubMed |
| 6-Gingerol Regulates the Exosomal miR-148b-3p/ACSL4/Ferroptosis Axis in an in vitro Model of Diabetic Retinopathy. | Diabetes Metab Syndr Obes | 2026 | 42703549 | PubTator, text mining | PubMed |
| The redox paradox in neurological disorders: balancing cytoprotection, ferroptosis, and therapeutic targeting. | Brain Res | 2026 | 42700879 | PubTator, text mining | PubMed |
| Sufentanil attenuates LPS-induced acute lung injury by suppressing ferroptosis and maintaining GPX4 protein abundance. | Front Cell Dev Biol | 2026 | 42698533 | PubTator, text mining | PubMed |
| Role of mitochondria-associated ER membranes in lipid metabolism: implications for renal lipotoxicity. | Biosci Rep | 2026 | 42693812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=2